92 related articles for article (PubMed ID: 12761496)
1. Paclitaxel increases p21 synthesis and accumulation of its AKT-phosphorylated form in the cytoplasm of cancer cells.
Héliez C; Baricault L; Barboule N; Valette A
Oncogene; 2003 May; 22(21):3260-8. PubMed ID: 12761496
[TBL] [Abstract][Full Text] [Related]
2. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity.
Giannakakou P; Robey R; Fojo T; Blagosklonny MV
Oncogene; 2001 Jun; 20(29):3806-13. PubMed ID: 11439344
[TBL] [Abstract][Full Text] [Related]
3. The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel.
Mitsuuchi Y; Johnson SW; Selvakumaran M; Williams SJ; Hamilton TC; Testa JR
Cancer Res; 2000 Oct; 60(19):5390-4. PubMed ID: 11034077
[TBL] [Abstract][Full Text] [Related]
4. Low doses of paclitaxel potently induce apoptosis in human retinoblastoma Y79 cells by up-regulating E2F1.
Drago-Ferrante R; Santulli A; Di Fiore R; Giuliano M; Calvaruso G; Tesoriere G; Vento R
Int J Oncol; 2008 Oct; 33(4):677-87. PubMed ID: 18813780
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin and p53 act on different pathways to induce G1 arrest in mammalian cells.
Metcalfe SM; Canman CE; Milner J; Morris RE; Goldman S; Kastan MB
Oncogene; 1997 Oct; 15(14):1635-42. PubMed ID: 9349496
[TBL] [Abstract][Full Text] [Related]
6. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of Taxol-induced cell death are concentration dependent.
Torres K; Horwitz SB
Cancer Res; 1998 Aug; 58(16):3620-6. PubMed ID: 9721870
[TBL] [Abstract][Full Text] [Related]
8. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
[TBL] [Abstract][Full Text] [Related]
9. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
10. TACC3 depletion sensitizes to paclitaxel-induced cell death and overrides p21WAF-mediated cell cycle arrest.
Schneider L; Essmann F; Kletke A; Rio P; Hanenberg H; Schulze-Osthoff K; Nürnberg B; Piekorz RP
Oncogene; 2008 Jan; 27(1):116-25. PubMed ID: 17599038
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells.
Zhou BP; Liao Y; Xia W; Spohn B; Lee MH; Hung MC
Nat Cell Biol; 2001 Mar; 3(3):245-52. PubMed ID: 11231573
[TBL] [Abstract][Full Text] [Related]
12. Perifosine, a novel alkylphospholipid, induces p21(WAF1) expression in squamous carcinoma cells through a p53-independent pathway, leading to loss in cyclin-dependent kinase activity and cell cycle arrest.
Patel V; Lahusen T; Sy T; Sausville EA; Gutkind JS; Senderowicz AM
Cancer Res; 2002 Mar; 62(5):1401-9. PubMed ID: 11888912
[TBL] [Abstract][Full Text] [Related]
13. Taxol induction of p21WAF1 and p53 requires c-raf-1.
Blagosklonny MV; Schulte TW; Nguyen P; Mimnaugh EG; Trepel J; Neckers L
Cancer Res; 1995 Oct; 55(20):4623-6. PubMed ID: 7553639
[TBL] [Abstract][Full Text] [Related]
14. The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells.
Poon RY; Chau MS; Yamashita K; Hunter T
Cancer Res; 1997 Nov; 57(22):5168-78. PubMed ID: 9371520
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel selects for mutant or pseudo-null p53 in drug resistance associated with tubulin mutations in human cancer.
Giannakakou P; Poy G; Zhan Z; Knutsen T; Blagosklonny MV; Fojo T
Oncogene; 2000 Jun; 19(27):3078-85. PubMed ID: 10871860
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicity.
Galmarini CM; Falette N; Tabone E; Levrat C; Britten R; Voorzanger-Rousselot N; Roesch-Gateau O; Vanier-Viornery A; Puisieux A; Dumontet C
Br J Cancer; 2001 Sep; 85(6):902-8. PubMed ID: 11556844
[TBL] [Abstract][Full Text] [Related]
17. Characterization of adriamycin-induced G2 arrest and its abrogation by caffeine in FL-amnion cells with or without p53.
Minemoto Y; Gannon J; Masutani M; Nakagama H; Sasagawa T; Inoue M; Masamune Y; Yamashita K
Exp Cell Res; 2001 Jan; 262(1):37-48. PubMed ID: 11120603
[TBL] [Abstract][Full Text] [Related]
18. Flavopiridol inversely affects p21(WAF1/CIP1) and p53 and protects p21-sensitive cells from paclitaxel.
Blagosklonny MV; Darzynkiewicz Z; Figg WD
Cancer Biol Ther; 2002; 1(4):420-5. PubMed ID: 12432259
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of p21(waf1) decreases G2-M arrest and apoptosis induced by paclitaxel in human sarcoma cells lacking both p53 and functional Rb protein.
Li W; Fan J; Banerjee D; Bertino JR
Mol Pharmacol; 1999 Jun; 55(6):1088-93. PubMed ID: 10347252
[TBL] [Abstract][Full Text] [Related]
20. Cytoplasmic p21 is responsible for paclitaxel resistance in ovarian cancer A2780 cells.
Xia X; Ji T; Liu R; Weng Y; Fang Y; Wang Z; Xu H
Eur J Gynaecol Oncol; 2015; 36(6):662-6. PubMed ID: 26775347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]